Who benefits most from expectancy effects? A combined neuroimaging and antidepressant trial in depressed older adults.
Ontology highlight
ABSTRACT: Depressed patients' expectations of improvement drive placebo effects in antidepressant clinical trials, yet there is considerable heterogeneity in the magnitude of expectancy effects. The present study seeks to identify those individuals who benefit most from expectancy effects using baseline neuroimaging and cognitive measures. Older adult outpatients diagnosed with major depressive disorder (MDD) participated in a prospective, 8-week clinical trial in which expectancy was experimentally manipulated and its effects on depression outcome measured. Based on the literature, we selected a priori 12 cognitive and brain-based variables linked to depression and expectancy, together with demographic variables, and incorporated them into a combined moderator. The combined moderator was developed
SUBMITTER: Zilcha-Mano S
PROVIDER: S-EPMC8443672 | biostudies-literature | 2021 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA